Home
Database Statistics
Help System
About
Literature
Projects
Events
Login / Register
Zebrafish as experimental model to establish the contribution of mutant p53 and ID4 to breast cancer angiogenesis in vivo.
2018
Magdalena Pruszko, and Elisa Milano, and Alicja Zylicz, and Maciej Zylicz, and Giovanni Blandino, and Giulia Fontemaggi
Department of Molecular Biology, International Institute of Molecular and Cell Biology in Warsaw, Warsaw, Poland.
Associated MeSH Terms
Cite
UI
MeSH Term
Description
Entries
Related Publications
Magdalena Pruszko, and Elisa Milano, and Alicja Zylicz, and Maciej Zylicz, and Giovanni Blandino, and Giulia Fontemaggi
The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis.
October 2009, Nature structural & molecular biology,
Magdalena Pruszko, and Elisa Milano, and Alicja Zylicz, and Maciej Zylicz, and Giovanni Blandino, and Giulia Fontemaggi
Zebrafish as an in vivo screening tool to establish PARP inhibitor efficacy.
January 2021, DNA repair,
Magdalena Pruszko, and Elisa Milano, and Alicja Zylicz, and Maciej Zylicz, and Giovanni Blandino, and Giulia Fontemaggi
The Chk1 inhibitor AZD7762 sensitises p53 mutant breast cancer cells to radiation in vitro and in vivo.
October 2012, Molecular medicine reports,
Magdalena Pruszko, and Elisa Milano, and Alicja Zylicz, and Maciej Zylicz, and Giovanni Blandino, and Giulia Fontemaggi
The rebel angel: mutant p53 as the driving oncogene in breast cancer.
November 2012, Carcinogenesis,
Magdalena Pruszko, and Elisa Milano, and Alicja Zylicz, and Maciej Zylicz, and Giovanni Blandino, and Giulia Fontemaggi
Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.
April 2016, Histopathology,
Magdalena Pruszko, and Elisa Milano, and Alicja Zylicz, and Maciej Zylicz, and Giovanni Blandino, and Giulia Fontemaggi
p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients.
January 2011, Breast cancer research : BCR,
Magdalena Pruszko, and Elisa Milano, and Alicja Zylicz, and Maciej Zylicz, and Giovanni Blandino, and Giulia Fontemaggi
Mutant p53 and genomic instability in a transgenic mouse model of breast cancer.
February 2000, Oncogene,
Magdalena Pruszko, and Elisa Milano, and Alicja Zylicz, and Maciej Zylicz, and Giovanni Blandino, and Giulia Fontemaggi
Kindlin-1 mutant zebrafish as an in vivo model system to study adhesion mechanisms in the epidermis.
September 2013, The Journal of investigative dermatology,
Magdalena Pruszko, and Elisa Milano, and Alicja Zylicz, and Maciej Zylicz, and Giovanni Blandino, and Giulia Fontemaggi
Mutant p53 in breast cancer: potential as a therapeutic target and biomarker.
July 2018, Breast cancer research and treatment,
Magdalena Pruszko, and Elisa Milano, and Alicja Zylicz, and Maciej Zylicz, and Giovanni Blandino, and Giulia Fontemaggi
ID4 regulates transcriptional activity of wild type and mutant p53 via K373 acetylation.
January 2017, Oncotarget,
Export Citation
×
Select Citation Style to be generated
APA
Vancouver
Harvard
BibTeX
Endnote
Generated Citation:
Selection Actions
Export Citations
Download Data
Save To My Collection
Need Help?
Explore features, get started with a guided tour, or view relevant help articles.
Start Tour
Go to Related Help Article
Copied contents to your clipboard!
Publications over Time
×
Save Item To Your Collection
×
Collection Name
Your saved publications will be grouped by this name - think of it like a folder to group related publications and results.
Use default name